#ALSTreatment
LightNews LightNews
4040rec.bsky.social
40:40 Recruitment
@4040rec.bsky.social
#Zydus #neurodegenerativedisease #neuroscience #neurology #neurodegeneration #USFDA #FDA #OrphanDrugDesignation #ODD #Usnoflast #NLRP3inhibitor #ALS #amyotrophiclateralsclerosis #ALStreatment #FDAapproval #ZydusLifesciences #Parkinsonsdisease #MultipleSclerosis
pharmatimes.com/news/zydus-a...
Zydus announces USFDA Orphan Drug Designation for Usnoflast in ALS treatment - PharmaTimes
Orphan drug designation offers development incentives and potential market exclusivity
pharmatimes.com
January 29, 2025 at 1:19 PM Everybody can reply
alsnewstoday.bsky.social
ALS News Today
@alsnewstoday.bsky.social
New ALS Drug in Development: https://bit.ly/47tX2N5

Eikonizo Therapeutics’ experimental oral therapy, EKZ-102, is expected to begin clinical testing in 2026.

#ALSNewsToday #Bionews #ALSResearch #ALSTreatment #EikonizoTherapeutics #NeurodegenerativeDisease #ALSNewsToday
Graphic summarizing a study on EKZ-438, a precursor to Eikonizo’s EKZ-102, showing potential benefits for ALS treatment by reducing abnormal protein buildup and improving motor neuron survival.
October 16, 2025 at 8:24 PM Everybody can reply
1 likes
1
alsnewstoday.bsky.social
ALS News Today
@alsnewstoday.bsky.social
Rethinking how ALS is treated: https://bit.ly/48j99O6

Northwestern researcher Hande Ozdinler believes progress in ALS treatment will come from understanding the brain’s role and designing therapies that target the disease’s many moving parts.

#ALS #ALSNewsToday #Bionews #ALSTreatment
Quote on ALS research: Progress in ALS understanding and therapy design, emphasizing upper motor neurons' role. Illustrated with a researcher and a brain diagram.
October 7, 2025 at 1:03 PM Everybody can reply
1 likes
1